Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (91-100 of 339) with videos related to

Pageof 34
Sort By:
Blood|September 30, 2004
Final adult height of patients who received hematopoietic cell transplantation in childhoodJean E Sanders, Katherine A Guthrie, Paul A Hoffmeister, et al.
Blood|June 12, 2010
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigmRoland B Walter, Frederick R Appelbaum, Martin S Tallman, et al.
Leukemia|October 14, 2018
Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesMegan Othus, Mikkael A Sekeres, Sucha Nand, et al.
Blood|May 27, 2004
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cellsDeborah E Banker, Sasha J Mayer, Henry Y Li, et al.
Haematologica|December 3, 2011
Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemiaRoland B Walter, Bruno C Medeiros, Bayard L Powell, et al.
Leukemia Research|September 24, 2004
Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cellsH Joachim Deeg, Peter Y Z Jiang, Leona A Holmberg, et al.
Leukemia Research|December 6, 2001
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanismDeborah E Banker, John J Cooper, Dean A Fennell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2012
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDSAaron T Gerds, Ted A Gooley, Elihu H Estey, et al.
Cancers|January 21, 2023
Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid LeukemiaCorentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Transplantation and Cellular Therapy|September 30, 2022
Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationCorentin Orvain, Mariia Byelykh, Megan Othus, et al.
Pageof 34

Showing results (91-100 of 339) with videos related to

Sort By:
Pageof 34
Blood|September 30, 2004
Final adult height of patients who received hematopoietic cell transplantation in childhoodJean E Sanders, Katherine A Guthrie, Paul A Hoffmeister, et al.
Blood|June 12, 2010
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigmRoland B Walter, Frederick R Appelbaum, Martin S Tallman, et al.
Leukemia|October 14, 2018
Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesMegan Othus, Mikkael A Sekeres, Sucha Nand, et al.
Blood|May 27, 2004
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cellsDeborah E Banker, Sasha J Mayer, Henry Y Li, et al.
Haematologica|December 3, 2011
Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemiaRoland B Walter, Bruno C Medeiros, Bayard L Powell, et al.
Leukemia Research|September 24, 2004
Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cellsH Joachim Deeg, Peter Y Z Jiang, Leona A Holmberg, et al.
Leukemia Research|December 6, 2001
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanismDeborah E Banker, John J Cooper, Dean A Fennell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2012
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDSAaron T Gerds, Ted A Gooley, Elihu H Estey, et al.
Cancers|January 21, 2023
Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid LeukemiaCorentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Transplantation and Cellular Therapy|September 30, 2022
Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationCorentin Orvain, Mariia Byelykh, Megan Othus, et al.
Pageof 34